InTest Corporation Receives $3.7 Million Medical Device Testing Order

- Order Advances InTest’s Diversification Strategy, Expands Alfamation’s Presence in Life Sciences -

MT. LAUREL, N.J.--(BUSINESS WIRE)-- InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor (“semi”), automotive/EV, defense/aerospace, industrial, life sciences, and safety/security, announced today that it was awarded a follow-on $3.7 million order by an existing customer that manufactures medical devices.

Alfamation, an InTest business, will be supplying multiple additional functional test systems to automate testing of high-volume medical devices as it expands its presence in targeted industries beyond automotive. The test solution utilizes multiple in-line, conveyor-based systems equipped with high-precision instruments and fixtures. This approach enhances process efficiency and supports high throughput, with the end goal of testing 50 million devices a year.

“This order is significant as it demonstrates our expertise in conducting high-performance electrical measurements by performing functional tests at the PCB level—a crucial capability for products that cannot be evaluated when fully assembled,” said Mauro Arigossi, CEO of Alfamation. “Functional test is a critical piece in ensuring medical devices operate safely and effectively and Alfamation is committed to supporting this process.”

About InTest Corporation
InTest Corporation is a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets including both the front-end and back-end of the semiconductor manufacturing industry (“semi”), automotive/EV, defense/aerospace, industrial, life sciences and safety/security. Backed by decades of engineering expertise and a culture of operational excellence, InTest solves difficult thermal, mechanical, and electronic challenges for customers worldwide while generating strong cash flow and profits. InTest’s growth strategy leverages these strengths to grow organically and with acquisitions through the addition of innovative technologies, deeper and broader geographic reach, customer penetration and market expansion. For more information, visit https://www.intest.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251209000168/en/

InTest Corporation

Duncan Gilmour

Chief Financial Officer and Treasurer

Tel: (856) 505-8999



Investors:

Sanjay Hurry

Alliance Advisors IR

INTTIR@Allianceadvisors.com

Tel: (212) 838-3777

Source: InTest Corporation